ScholarWorks@Korea University

Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma

Full metadata record
DC Field Value Language
dc.contributor.authorPark, J.-W.-
dc.contributor.authorLee, J.H.-
dc.contributor.authorSuh, K.-S.-
dc.contributor.authorChung, J.W.-
dc.contributor.authorSeong, J.-
dc.contributor.authorLee, J.S.-
dc.contributor.authorTak, W.Y.-
dc.contributor.authorBae, S.H.-
dc.contributor.authorYeon, J.E.-
dc.contributor.authorChoi, M.S.-
dc.contributor.authorKim, Y.J.-
dc.contributor.authorLim, Y.-S.-
dc.contributor.authorKim, J.H.-
dc.contributor.authorKim, D.Y.-
dc.contributor.authorKim, H.Y.-
dc.contributor.authorKim, B.H.-
dc.contributor.authorLim, H.Y.-
dc.contributor.authorKim, K.S.-
dc.contributor.authorKim, S.H.-
dc.contributor.authorChoi, G.H.-
dc.contributor.authorKim, D.-S.-
dc.contributor.authorKim, J.M.-
dc.contributor.authorCho, J.Y.-
dc.contributor.authorLee, H.W.-
dc.contributor.authorYi, N.-J.-
dc.contributor.authorLee, J.M.-
dc.contributor.authorKoh, Y.H.-
dc.contributor.authorKim, H.B.-
dc.contributor.authorKim, Y.K.-
dc.contributor.authorLee, M.W.-
dc.contributor.authorChoi, J.-Y.-
dc.contributor.authorLee, S.S.-
dc.contributor.authorShin, J.H.-
dc.contributor.authorCho, S.B.-
dc.contributor.authorCho, Y.K.-
dc.contributor.authorKim, T.H.-
dc.contributor.authorKim, M.-S.-
dc.contributor.authorKim, J.H.-
dc.contributor.authorPark, H.C.-
dc.contributor.authorKay, C.S.-
dc.contributor.authorYoon, W.S.-
dc.contributor.authorChie, E.K.-
dc.contributor.authorKorean Liver Cancer Study Group (KLCSG)-
dc.contributor.authorNational, Cancer Center-
dc.contributor.authorKorea, (NCC)-
dc.date.accessioned2021-09-04T23:54:11Z-
dc.date.available2021-09-04T23:54:11Z-
dc.date.created2021-06-17-
dc.date.issued2015-
dc.identifier.issn1976-2283-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/95906-
dc.description.abstractThe guideline for the management of hepatocellular carcinoma (HCC) was first developed in 2003 and revised in 2009 by the Korean Liver Cancer Study Group and the National Cancer Center, Korea. Since then, many studies on HCC have been carried out in Korea and other countries. In particular, a substantial body of knowledge has been accumulated on diagnosis, staging, and treatment specific to Asian characteristics, especially Koreans, prompting the proposal of new strategies. Accordingly, the new guideline presented herein was developed on the basis of recent evidence and expert opinions. The primary targets of this guideline are patients with suspicious or newly diagnosed HCC. This guideline provides recommendations for the initial treatment of patients with newly diagnosed HCC. © 2015, Joe Bok Chung. All rights reserved.-
dc.languageEnglish-
dc.language.isoen-
dc.publisherEditorial Office of Gut and Liver-
dc.subjectanalgesic agent-
dc.subjectantineoplastic agent-
dc.subjectantivirus agent-
dc.subjectcytotoxic agent-
dc.subjectimmunosuppressive agent-
dc.subjectsorafenib-
dc.subjectablation therapy-
dc.subjectadjuvant therapy-
dc.subjectanalgesia-
dc.subjectantiviral therapy-
dc.subjectartificial embolism-
dc.subjectcadaver donor-
dc.subjectcancer adjuvant therapy-
dc.subjectcancer chemotherapy-
dc.subjectcancer diagnosis-
dc.subjectcancer epidemiology-
dc.subjectcancer pain-
dc.subjectcancer patient-
dc.subjectcancer prevention-
dc.subjectcancer radiotherapy-
dc.subjectcancer staging-
dc.subjectcancer surgery-
dc.subjectcancer transplantation-
dc.subjectchemoembolization-
dc.subjectchemotherapy-
dc.subjectclinical trial (topic)-
dc.subjectcomputer assisted tomography-
dc.subjectcryoablation-
dc.subjectevidence based practice-
dc.subjectexternal beam radiotherapy-
dc.subjectfollow up-
dc.subjecthepatic arterial infusion chemotherapy-
dc.subjecthepatitis B-
dc.subjecthepatitis C-
dc.subjecthigh intensity focused ultrasound-
dc.subjecthigh risk population-
dc.subjectholmium injection therapy-
dc.subjecthuman-
dc.subjectimmunosuppressive treatment-
dc.subjectKorea-
dc.subjectKorean (people)-
dc.subjectlaser surgery-
dc.subjectliver cell carcinoma-
dc.subjectliver resection-
dc.subjectliver transplantation-
dc.subjectmicrowave therapy-
dc.subjectmulticenter study (topic)-
dc.subjectmultimodality cancer therapy-
dc.subjectnonsurgical invasive therapy-
dc.subjectpercutaneous ethanol injection-
dc.subjectphase 2 clinical trial (topic)-
dc.subjectphase 3 clinical trial (topic)-
dc.subjectpractice guideline-
dc.subjectprofessional knowledge-
dc.subjectradiodiagnosis-
dc.subjectradioembolization-
dc.subjectradiofrequency ablation-
dc.subjectrandomized controlled trial (topic)-
dc.subjectReview-
dc.subjectsalvage therapy-
dc.subjectsystemic therapy-
dc.subjecttreatment response-
dc.subjecttumor ablation-
dc.subjectvirus carrier-
dc.subjectCarcinoma, Hepatocellular-
dc.subjectLiver Neoplasms-
dc.subjectpractice guideline-
dc.subjectprimary prevention-
dc.subjectsecondary prevention-
dc.subjectSouth Korea-
dc.subjectCarcinoma, Hepatocellular-
dc.subjectEvidence-Based Practice-
dc.subjectHepatectomy-
dc.subjectHumans-
dc.subjectLiver Neoplasms-
dc.subjectLiver Transplantation-
dc.subjectPrimary Prevention-
dc.subjectRepublic of Korea-
dc.subjectSecondary Prevention-
dc.title2014 KLCSG-NCC Korea practice guideline for the management of hepatocellular carcinoma-
dc.typeArticle-
dc.contributor.affiliatedAuthorCho, S.B.-
dc.identifier.doi10.5009/gnl14460-
dc.identifier.scopusid2-s2.0-84928811506-
dc.identifier.bibliographicCitationGut and Liver, v.9, no.3, pp.267 - 317-
dc.relation.isPartOfGut and Liver-
dc.citation.titleGut and Liver-
dc.citation.volume9-
dc.citation.number3-
dc.citation.startPage267-
dc.citation.endPage317-
dc.type.rimsART-
dc.type.docTypeReview-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.subject.keywordPlusanalgesic agent-
dc.subject.keywordPlusantineoplastic agent-
dc.subject.keywordPlusantivirus agent-
dc.subject.keywordPluscytotoxic agent-
dc.subject.keywordPlusimmunosuppressive agent-
dc.subject.keywordPlussorafenib-
dc.subject.keywordPlusablation therapy-
dc.subject.keywordPlusadjuvant therapy-
dc.subject.keywordPlusanalgesia-
dc.subject.keywordPlusantiviral therapy-
dc.subject.keywordPlusartificial embolism-
dc.subject.keywordPluscadaver donor-
dc.subject.keywordPluscancer adjuvant therapy-
dc.subject.keywordPluscancer chemotherapy-
dc.subject.keywordPluscancer diagnosis-
dc.subject.keywordPluscancer epidemiology-
dc.subject.keywordPluscancer pain-
dc.subject.keywordPluscancer patient-
dc.subject.keywordPluscancer prevention-
dc.subject.keywordPluscancer radiotherapy-
dc.subject.keywordPluscancer staging-
dc.subject.keywordPluscancer surgery-
dc.subject.keywordPluscancer transplantation-
dc.subject.keywordPluschemoembolization-
dc.subject.keywordPluschemotherapy-
dc.subject.keywordPlusclinical trial (topic)-
dc.subject.keywordPluscomputer assisted tomography-
dc.subject.keywordPluscryoablation-
dc.subject.keywordPlusevidence based practice-
dc.subject.keywordPlusexternal beam radiotherapy-
dc.subject.keywordPlusfollow up-
dc.subject.keywordPlushepatic arterial infusion chemotherapy-
dc.subject.keywordPlushepatitis B-
dc.subject.keywordPlushepatitis C-
dc.subject.keywordPlushigh intensity focused ultrasound-
dc.subject.keywordPlushigh risk population-
dc.subject.keywordPlusholmium injection therapy-
dc.subject.keywordPlushuman-
dc.subject.keywordPlusimmunosuppressive treatment-
dc.subject.keywordPlusKorea-
dc.subject.keywordPlusKorean (people)-
dc.subject.keywordPluslaser surgery-
dc.subject.keywordPlusliver cell carcinoma-
dc.subject.keywordPlusliver resection-
dc.subject.keywordPlusliver transplantation-
dc.subject.keywordPlusmicrowave therapy-
dc.subject.keywordPlusmulticenter study (topic)-
dc.subject.keywordPlusmultimodality cancer therapy-
dc.subject.keywordPlusnonsurgical invasive therapy-
dc.subject.keywordPluspercutaneous ethanol injection-
dc.subject.keywordPlusphase 2 clinical trial (topic)-
dc.subject.keywordPlusphase 3 clinical trial (topic)-
dc.subject.keywordPluspractice guideline-
dc.subject.keywordPlusprofessional knowledge-
dc.subject.keywordPlusradiodiagnosis-
dc.subject.keywordPlusradioembolization-
dc.subject.keywordPlusradiofrequency ablation-
dc.subject.keywordPlusrandomized controlled trial (topic)-
dc.subject.keywordPlusReview-
dc.subject.keywordPlussalvage therapy-
dc.subject.keywordPlussystemic therapy-
dc.subject.keywordPlustreatment response-
dc.subject.keywordPlustumor ablation-
dc.subject.keywordPlusvirus carrier-
dc.subject.keywordPlusCarcinoma, Hepatocellular-
dc.subject.keywordPlusLiver Neoplasms-
dc.subject.keywordPluspractice guideline-
dc.subject.keywordPlusprimary prevention-
dc.subject.keywordPlussecondary prevention-
dc.subject.keywordPlusSouth Korea-
dc.subject.keywordPlusCarcinoma, Hepatocellular-
dc.subject.keywordPlusEvidence-Based Practice-
dc.subject.keywordPlusHepatectomy-
dc.subject.keywordPlusHumans-
dc.subject.keywordPlusLiver Neoplasms-
dc.subject.keywordPlusLiver Transplantation-
dc.subject.keywordPlusPrimary Prevention-
dc.subject.keywordPlusRepublic of Korea-
dc.subject.keywordPlusSecondary Prevention-
dc.subject.keywordAuthorCarcinoma, hepatocellular-
dc.subject.keywordAuthorGuidelines-
dc.subject.keywordAuthorManagement-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles
Show simple item record

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Cho, Sung Bum photo

Cho, Sung Bum
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

STATISTICS
Total View :8,716,405
Today View :47,895

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(02841) 서울특별시 성북구 안암로 14502-3290-1114

COPYRIGHT © 2021 Korea University. All Rights Reserved.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

English